Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms

Hormone and Metabolic Research

Volumn 38, Issue 12, 2006, Pages 812-816

  Pérez Castrillón, José L ^a   Justo, I ^a   Sanz, A ^b   De Luis, D ^a   Duenas A ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

1.25 Dihydroxyvitamin D; Angiotentensin converting enzyme; Hypertension; Insertion deletion polymorphism

Indexed keywords

CALCITRIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; QUINAPRIL; VITAMIN D;

ADULT; AGED; ARTICLE; CALCIUM METABOLISM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ENZYME POLYMORPHISM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCITRIOL; CALCIUM; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TETRAHYDROISOQUINOLINES;

EID: 33846023052     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-956500     Document Type: Article

References (22)

1. 3. J Clin Invest 2002; 110: 155-156
2. Giner V, Corella D, Chaves FJ, Pascual JM. Portoles O, Marin P, Lozano JV, Armengod ME, Redon J. Polimorfismos genéticos del sistema renina-angiotensina e hipertensión arterial esencial en la población española. Med Clin (Barc) 2001; 117: 525-529
3. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin converting enzyme in the human heart effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388
4. Fray JC, Park CS, Valentine AN. Calcium and the control of renin secretion. Endocr Rev 1987; 8: 53-93
5. Burgess ED, Hawkins RG, Wanatabe M. Interaction of 1,25-dihydroxivitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990; 3: 903-905
6. Resnick LM, Muller FB, Laragh JH. Calcium regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Int Med 1986; 105: 649-654
7. Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitan MC, Gil A. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors. Am J Hypertens 1994; 7: 46-51
8. John SW, Weitzner G, Rozen R, Scriver CR. A rapid method for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991; 19: 408
9. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3: 120-121
10. Rigat B, Hubert P, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1 dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433
11. Perna NT, Batzer MA, Deininger PL, Stoneking M. Alu insertion polymorphism: A new type of marker for human population studies. Hum Biol 1992; 64: 641-648
12. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501
13. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238
14. 3 1α-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med 2001; 110: 687-693
15. Wolf G, Bohlender J, Bondeva T, Roger T, Thaiss F, Wenzel UO. Angiotensin II Upregulates Toll-Like Receptor 4 on Mesangial Cells. J Am Soc Nephrol 2006, (E-pub ahead)
16. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773
17. Krystal-Boneh E, Froom P, Harari G, Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997; 30: 1289-1294
18. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-1637
19. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, Cranney A, Adachi J, Tugwell P, Josse R, Greenwood C, Guyatt G, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-Analysis of the efficacy of Vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23: 560-569
20. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-357
21. Itonaga I, Sabokbar A, Neale SD, Athanasou NA. 1,25-Dihydroxyvitamin D3 and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochem Biophys Res Commun 1999; 264: 590-595
22. Perez-Castrillon JL, Silva J, Justo I, Sanz A, Martin-Luquero M, Igea R, Escudero P, Pueyo C, Diaz C, Hernandez G, Duenas A. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: Relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 2003; 16: 453-459